The role of melatonin in regulating sleep wake disorders in children attending the developmental pediatrics outpatient service of a tertiary care hospital in South India
DOI:
https://doi.org/10.18203/2349-3291.ijcp20230735Keywords:
Melatonin, Sleep disorders, Neuro-developmental challenge, Sleep-wake rhythm disordersAbstract
Background: We have observed that 75% of children with neurodevelopmental challenges visiting the Developmental Pediatrics department of this institution have sleep wake disorders. Disturbed sleep has a negative effect on learning and behavior. In this study we assessed the effectiveness of melatonin in improving sleep wake disorders in children with developmental compromise from this south Indian state.
Methods: Children with developmental challenges having sleep wake disorders confirmed by the pediatric insomnia severity index PISI, who were prescribed a daily dose of 3mg of melatonin participated in this prospective, observational, longitudinal study if the parents gave written informed consent. Parents were educated in the practice of sleep hygiene. The sleep disturbance scale for children (SDSC) was used to assess the overall pattern of sleep and six common disorders before and three weeks after starting melatonin.
Results: Based on the PISI scores, 13, 58 and 20 children had mild, moderate and severe insomnia respectively. Melatonin improved sleep latency, increased duration of sleep, decreased night awakenings, crying spells, dreams and daytime drowsiness. There was a significant improvement in the sleep pattern as indicated by better scores in the total SDSC score as well the scores for the six sleep disorders (p<0.001).
Conclusions: Melatonin has a significant role to play in regulating duration and quality of sleep and improving sleep pattern in developmentally challenged children with sleep-wake disorders.
References
Owens JA, Rosen CL, Mindell JA. Medication use in the treatment of pediatric insomnia. Pediatrics. 2003; 111:628-35.
Mindell JA, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents. Pediatrics. 2006;117(6):1223-32.
Abdelgadir IS, Gordon MA, Akobeng AK. Arch Dis Child. 2018;103:1155-62.
Byars, K, Simon SL, Peugh J. Validation of a brief insomnia severity measure in youth clinically referred for sleep evaluation. J Pediatr Psychol. 2017; 42(4):466-75.
Bruni O, Ottaviano S, Guidetti V. The sleep disturbance scale for children (SDSC). J Sleep Res. 1996;5(4):251-61.
Owens JA, Babcock D, Blumer J. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. J Clin Sleep Med. 2005;1(1):49-59.
Jan JE, Owens JA, Weiss MD, Johnson KP, Wasdell MB, Freeman RD, Ipsiroglu OS. Sleep hygiene for children with neurodevelopmental disabilities. Pediatrics 2008;122;1343-50.
Cummings C. Melatonin for the management of sleep disorders in children and adolescents. Pediatr Child Health. 2012;17(6):331-3.
Braam W, Smits M, Didden R. Exogenous melatonin for sleep problems in individuals with intellectual disability. Develop Med Child Neurol. 2009;51:340-9.
NMaster Sample size calculation software. Available at: https://www.cmc-biostatistics.ac.in/nmaster/. Accessed on 20 November 2022.
Ayyash HF, Preece P, Morton R. Melatonin for sleep disturbance in children with neurodevelopmental disorders. Expert Rev Neurother. 2015;5:1-7.
Gennaro LD, Ferrara M. Sleep spindles: an overview. Sleep Med Rev. 2003;7(5):423-40.
Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatr. 2006; 45(5):512-9.
Smits MG, Nagtegaal EE, van der Heijden J, Coenen AM, Kerkhof GA. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol. 2001;16(2):86-92.
Schwichtenberg AJ. Melatonin treatment in children with developmental disabilities. Sleep Med Clin. 2015;10(2):181-7.
Rossignol DA, Frye RE. Melatonin in autism spectrum disorders. Dev Med Child Neurol. 2011; 53(9):783-92.
Andersen MI, Kaczmarska J, McGrew GS. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008;23:482-5.
Hoebert M, van der Heijden KB, van Geijlswijk IM. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009;47(1):1-7.
Dutt R, Roduta-Roberts M, Brown CA. Sleep and children with cerebral palsy: a review of current evidence and environmental non-pharmacological interventions. Children. 2015;2:78-88.
